Journal of Clinical & Experimental OncologyISSN: 2324-9110

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Pimradasiri Srijiwangsa Author

Subjects of specialization
Colorectal cancer, Cancer chemotherapy, Prostate biomarker, Endometrial cancer

Affiliation
Chulabhorn International College of Medicine, Thammasat University, Pathum Thani, Thailand

Biography

Pimradasiri Srijiwangsa was working in the Chulabhorn International College of Medicine, Thammasat University, Pathum Thani, Thailand. He has more than 40 publications. His current research area related to osteoarthropathy


Publications

Review Article Open Access

Roles of NAD (P) H-Quinone Oxidoreductase 1 (NQO1) On Cancer Progression and Chemoresistance

Author(s):

Pimradasiri Srijiwangsa and Kesara Na-Bangchang

NAD(P)H-Quinone Oxidoreductase 1 (NQO1), originally referred to as DT-diaphorase, is a xenobiotic metabolizing/antioxidant enzyme that detoxifies chemical stressors, providing cytoprotection in normal tissues. NQO1 catalyzes obligatory two-electron reduction of several endogenous and environmental quinones to hydroquinone that are ready for further conjugation and excretion. The enzyme requires NADH or NADPH as an electron donor for enzymatic activity. High-level of NQO1 expression has however, been correlated with numerous human malignancies, suggesting its role in cancer progression and chemoresistance. This adaptation renders the cancer cells to survive in relatively high oxidative stress condition compared to normal cells, as well as protects cancer cell... view moreĀ»

DOI: 10.4172/2324-9110.1000192

Abstract HTML PDF



Google Scholars / Researchers Sites

GET THE APP